Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

The Link Between Erectile Dysfunction and Cardiovascular Disease: Understanding the Connection

Medically reviewed by 
The Link Between Erectile Dysfunction and Cardiovascular Disease: Understanding the Connection

Erectile dysfunction (ED) and cardiovascular disease (CVD) represent significant health challenges, impacting both sexual health and cardiovascular well-being. These seemingly disparate issues share a complex, interconnected relationship that warrants careful examination. This article explores the established link between ED and CVD, aiming to elucidate the intricate physiological connections that bind these conditions. Beyond their surface distinctions, we will explore how ED may be an early indicator of underlying cardiovascular dysfunction, offering insights beyond conventional perspectives.


What Is Erectile Dysfunction?

Erectile dysfunction is characterized by the consistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. This issue can arise from a complex interplay of physical and psychological factors. Physiologically, ED commonly stems from vascular problems, hormonal imbalances, and neurological disorders that affect the intricate mechanisms of penile erection. Common physical causes of erectile dysfunction include cardiometabolic disease, Parkinson's disease, multiple sclerosis, prescription medications, tobacco use and substance abuse, sleep disorders, low testosterone, and injury to the pelvic area. (20

Psychological factors also play a significant role in ED, with stress, anxiety, depression, and relationship issues being potential triggers. The intricate connection between the mind and body underscores the importance of a holistic approach in addressing ED. (20

ED is very common, with one review finding the global prevalence of ED to be as high as 76.5%. The frequency of ED increases with age due to accumulating risk factors. The Massachusetts Male Aging Study found that over half of all men experience some form of ED and that ED prevalence increases between 5-15% between the ages of 40-70. However, research also indicates a notable prevalence of ED across various age groups, dispelling the misconception that it solely affects older individuals. According to one study, ED affects 26% of men younger than 40.

The impact of ED extends beyond the physical realm, having a profound effect on the quality of life for individuals and their partners. Beyond the obvious implications for sexual function, ED can lead to emotional distress, decreased self-esteem, and strained relationships. Therefore, addressing ED's physical and psychological aspects is paramount for comprehensive and successful management, emphasizing the importance of a collaborative approach between healthcare providers and patients.

Cardiovascular Disease: An Overview

CVD encompasses a range of conditions affecting the heart and blood vessels. In the United States, one person dies every 33 seconds from CVD. In 2021, heart disease was responsible for one in every five deaths. (25

The various forms of cardiovascular disease include coronary artery disease, heart failure, valvular heart diseases, and arrhythmias. Risk factors for CVD can be broadly categorized as modifiable and non-modifiable. Modifiable risk factors are those that can be controlled, including lifestyle choices such as a sedentary lifestyle, poor dietary habits, smoking, and excessive alcohol consumption. These behaviors often contribute to conditions like obesity, hypertension, and dyslipidemia, creating a conducive environment for cardiovascular complications. Non-modifiable risk factors cannot be controlled and include gender, race, and advancing age. (48

Genetic factors also play a role in CVD, with a hereditary component contributing to conditions such as familial hypercholesterolemia and certain congenital heart diseases. The risk of developing CVD increases by approximately 40% in siblings of individuals with CVD; moreover, children of parents with premature CVD face a heightened risk increase ranging from 60-75% (31). 

The Connection Between ED and CVD

The link between ED and CVD is predominantly related to vascular health and endothelial function. Both conditions often stem from compromised blood flow, emphasizing the systemic nature of cardiovascular health.

ED is intricately linked to disruptions in smooth muscle relaxation, vascular dilation, and nitric oxide (NO) signaling. Normally, during sexual arousal, the release of NO by nerve endings and endothelial cells stimulates the production of cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the penile arteries and corpus cavernosum. This cascade of events leads to the relaxation of smooth muscles, allowing increased blood flow into the penile tissues and engorgement of the erectile tissue. Pathology in any of these processes can result in ED due to an impaired ability to relax smooth muscle and compromised vascular dilation. (35

Almost 50% of men diagnosed with coronary artery disease demonstrate notable ED. This correlation arises due to similarities in the size and atherosclerotic susceptibility of the coronary and cavernosal arteries. Atherosclerosis is the buildup of a sticky substance called plaque inside arteries, narrowing the affected vasculature. The penile cavernosal arteries, being smaller, are susceptible to the consequences of atherosclerosis because plaque accumulation can impede blood flow, affecting the ability to achieve and sustain an erection. Additionally, endothelial dysfunction, a common precursor to atherosclerosis, diminishes the release of nitric oxide.

ED as an Early Indicator of CVD

Numerous scientific studies substantiate the correlation between ED and an increased risk of CVD. Published research has consistently demonstrated that men with ED are more likely to exhibit early signs of cardiovascular compromise, such as endothelial dysfunction and arterial stiffness. Moreover, the severity of ED correlates with the extent of cardiovascular involvement and vascular dysfunction. Longitudinal studies have further illuminated ED as an independent predictor of future cardiovascular events, emphasizing its role as a sentinel marker for underlying vascular issues. (40

The findings from the Prostate Cancer Prevention Trial indicate that experiencing ED raises a man's CVD risk to a level comparable to that of smoking or possessing a family history of heart attacks. Younger men (age 40-49) with unexplained ED have a 50-fold increase in 10-year incidence of heart disease compared to men in the same age group without ED. This finding suggests that vasculogenic ED is an early indicator of coronary disease, preceding its development by decades. 

ED is also associated with an increased risk of cardiovascular events and all-cause mortality. A meta-analysis of 14 studies, including a total of over 90,000 men with ED, found that this population had 44% more total cardiovascular events, 62% more heart attacks, 39% more strokes, and a 25% increased all-cause risk of death compared to patients without ED.

The implications of ED as an early indicator of CVD are profound, as it provides a tangible window of opportunity for preventive measures. Recognizing ED as a potential red flag prompts healthcare providers to delve deeper into cardiovascular risk assessments, facilitating early diagnosis of underlying vascular issues. This proactive approach is crucial given that CVD often progresses silently, with clinical symptoms appearing only at advanced stages. By addressing ED, healthcare practitioners and patients can implement lifestyle modifications, initiate cardiovascular risk reduction strategies, and, if necessary, prescribe pharmacological interventions to not only treat sexual dysfunction but mitigate the progression of CVD.

Managing ED and Reducing CVD Risk

Managing ED goes hand in hand with implementing intervention strategies that help reduce CVD risk. 

Lifestyle interventions play a pivotal role in improving both ED and cardiovascular outcomes. A heart-healthy diet, rich in fruits, vegetables, whole grains, and lean proteins, contributes to better vascular function. The Mediterranean diet, in particular, has been associated with a lower risk of both ED and CVD. The PREDIMED trial is a landmark study that demonstrated that adherence to the Mediterranean diet significantly reduces the risk of cardiovascular events, including heart attack and strokes, by a remarkable 30%. Another study investigated the impact of the Mediterranean diet on endothelial function and erectile dysfunction in patients with hypertension. Findings from the study suggested that adherence to the diet was associated with improved endothelial function and erectile performance by increasing endogenous testosterone levels.

Regular physical activity is a cornerstone in managing CVD risk. Exercise improves blood flow, enhances endothelial function, and helps maintain a healthy weight, blood pressure, and lipid profile. Engaging in frequent exercise has been linked to a decreased risk of developing CVD and cardiovascular-related mortality. A study published in The Journal of Sexual Medicine in December 2023 found exercising at least 30 minutes three times a week is as effective as Viagra in improving erectile dysfunction.

Smoking cessation is another critical component of supporting cardiovascular health. Smoking contributes to ED by impairing blood vessel function and significantly increases the risk of CVD (23, 32). Quitting smoking improves both sexual and cardiovascular health. Research has found that spontaneous erection during sleep and penile rigidity significantly improve as soon as 24 hours after smoking cessation. 

The role of gut health in ED and CVD management is an emerging area of interest. A large study of over 17,000 men found that those with irritable bowel syndrome (IBS) were 2.92 times more likely to have ED than those without IBS. While dysbiosis has been recognized as contributing to IBS for quite some time, newer research suggests a potential link between the gut microbiota and cardiovascular function (termed the "gut-heart axis"). Gut microbiome metabolites, such as short-chain fatty acids (SCFAs) and trimethylamine-N-oxide (TMAO), modulate vascular function by influencing inflammation, lipid metabolism, and atherosclerosis. Understanding the relationship between the gut and vascular health offers potential strategies for preserving vascular and erectile function. Research suggests that taking certain probiotic strains, including L. plantarum 299v and L. rhamnosus GG, could improve CVD by modulating pro-inflammatory immune responses and reducing the number of inflammatory cytokines in circulation.

In cases where lifestyle modifications alone may not suffice, medical interventions are available. Medications like phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil (Viagra), are commonly prescribed for ED. Beyond their immediate impact on erectile function, these medications have demonstrated vasculoprotective effects, potentially contributing to cardiovascular health. 

When to Seek Medical Help

Considering its profound impact on sexual health, psychological well-being, and its potential role as an indicator of underlying cardiovascular dysfunction, seeking medical help for ED is always recommended. The multifaceted nature of ED requires a comprehensive evaluation by healthcare providers who can address the condition's physical and psychological aspects. Beyond its immediate impact on sexual function, ED has been linked to psychological issues such as anxiety, depression, and decreased quality of life. Moreover, the close association between ED and cardiovascular health necessitates a thorough examination to identify potential cardiovascular risk factors and prevent future complications.

During the evaluation, healthcare providers will inquire about the onset and duration of ED, associated symptoms, and any potential contributing factors, such as lifestyle choices or medications. A detailed medical history is crucial in identifying underlying conditions that may contribute to ED, including diabetes, hypertension, or hormonal imbalances. Additionally, a comprehensive physical examination may be conducted to assess cardiovascular health and identify potential anatomical or neurological issues.

Diagnostic tests may be employed to further evaluate the underlying causes of ED. These can include blood tests to assess hormonal levels, lipid profiles, and blood glucose levels. Imaging studies, such as ultrasound, may be utilized to evaluate blood flow to the penile region, providing insights into vascular function. Specialized tests like nocturnal penile tumescence testing may be employed to assess the natural erectile function during sleep.

Overall, the consultation process aims to uncover the root causes of ED and tailor interventions accordingly. It offers an opportunity for healthcare providers to address not only the immediate concern of sexual dysfunction but also to identify and manage any underlying health issues. The collaborative approach between healthcare professionals and individuals experiencing ED is instrumental in developing personalized treatment plans that encompass lifestyle modifications, psychological support, and, when necessary, pharmacological interventions. Seeking professional guidance ensures a holistic and effective approach to managing ED, promoting both sexual and overall health.


Key Takeaways

The intricate link between ED and CVD underscores the importance of recognizing ED as a potential early marker for cardiovascular issues. Shared vascular mechanisms make ED not merely a localized concern but a valuable indicator of systemic health. The evidence-based understanding of this connection emphasizes the need for a comprehensive approach to both sexual and cardiovascular health.

Individuals experiencing ED are urged to take a proactive stance toward their health. Seeking timely medical advice allows healthcare professionals to conduct thorough evaluations, identify potential risk factors, and develop personalized interventions for affected individuals. Lifestyle changes, such as adopting a heart-healthy diet, engaging in regular physical activity, and quitting smoking, play a pivotal role in managing both ED and CVD risk factors. By addressing these aspects, individuals can not only enhance their sexual well-being but also mitigate the risk of future cardiovascular complications. Embracing a holistic approach to health empowers individuals to make informed choices, fostering a pathway to improved overall well-being and a healthier future.

The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article

No items found.


  1. Allen, M. S., & Tostes, R. C. (2023). Cigarette smoking and erectile dysfunction: an updated review with a focus on pathophysiology, e-cigarettes, and smoking cessation. Sexual Medicine Reviews, 11(1), 61–73.
  2. Angelis, A., Aggeli, K., Dimitroglou, I., et al. (2021). Exercise capacity benefit in relation to endogenous testosterone, coronary and central vascular physiology, and the Mediterranean regime in hypertensive males with erectile dysfunction. European Heart Journal, 42(Supplement_1).
  3. Blake, K. (2023, April 28). What Is a Heart Healthy Diet and Who Should Follow One? Rupa Health.
  4. Capogrosso, P., Colicchia, M., Ventimiglia, E., et al. (2013). One Patient Out of Four with Newly Diagnosed Erectile Dysfunction Is a Young Man—Worrisome Picture from the Everyday Clinical Practice. The Journal of Sexual Medicine, 10(7), 1833–1841.
  5. Cardiovascular Diseases. (2020, May 26). CDC.
  6. Cavernous Artery. ScienceDirect. Retrieved February 28, 2024, from
  7. Chao, C.-H., Lin, C.-L., Wang, H.-Y., et al. (2013). Increased subsequent risk of erectile dysfunction in patients with irritable bowel syndrome: a nationwide population-based cohort study. Andrology, 1(5), 793–798.
  8. Christie, J. (2023, January 6). A functional medicine approach to obesity and weight management. Rupa Health.
  9. Chung, E. (2019). Contemporary and Novel Imaging Studies for the Evaluation of Erectile Dysfunction. Medical Sciences, 7(8), 87–87.
  10. Cloyd, J. (2023, April 27). Unlocking the Health Benefits of Nitric Oxide: How This Molecule Supports Cardiovascular Health, Exercise Performance, and More. Rupa Health.
  11. Cloyd, J. (2023, May 17). The Role Of Nutrition And Dietary Supplements In Preventing And Managing Cardiovascular Disease. Rupa Health.
  12. Cloyd, J. (2023, July 3). The Role of Physical Activity in Promoting Heart Health. Rupa Health.
  13. Cloyd, J. (2023, September 28). A Holistic Functional Medicine Protocol For Multiple Sclerosis. Rupa Health.
  14. Cloyd, K. (2023, November 10). Erectile Health and the Gut: Surprising Connections Unveiled. Rupa Health.
  15. Cloyd, K. (2023, December 19). How to interpret your lipid panel results. Rupa Health.
  16. Creedon, K. (2022, July 14). Simple lifestyle changes that can help keep high blood pressure under control. Rupa Health.
  17. Davignon, J. (2004). Role of Endothelial Dysfunction in Atherosclerosis. Circulation, 109(23_suppl_1), III–27III–32.
  18. Duncan, M. S., Freiberg, M. S., Greevy, R. A., et al. (2019). Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease. JAMA, 322(7), 642.
  19. Easthope, A. (2022, April 26). 11 Common Causes Of Low Male Testosterone (And How To Fix Them). Rupa Health.
  20. Erectile dysfunction. (2022, March 29). Mayo Clinic.
  21. Estruch, R., Ros, E., Salas-Salvadó, J., et al. (2018). Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. New England Journal of Medicine, 378(25), e34.
  22. Feldman, H. A., Goldstein, I., Hatzichristou, D. G., et al. (1994). Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study. Journal of Urology, 151(1), 54–61.
  23. Gallucci, G., Tartarone, A., Lerose, R., et al. (2020). Cardiovascular risk of smoking and benefits of smoking cessation. Journal of Thoracic Disease, 12(7), 3866–3876.
  24. Hajar, R. (2020). Genetics in Cardiovascular Disease. Heart Views, 21(1), 55.
  25. Heart Disease Facts. (2023, May 15). Centers for Disease Control and Prevention.
  26. Hutchings, D. C., Anderson, S. G., Caldwell, J. L., et al. (2018). Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection? Heart, 104(15), 1244–1250.
  27. Inman, B. A., Sauver, J. L. S., Jacobson, D. J., et al. (2009). A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clinic Proceedings, 84(2), 108–113.
  28. Kessler, A., Sollie, S., Challacombe, B., et al. (2019). The global prevalence of erectile dysfunction: a review. BJU International, 124(4), 587–599.
  29. Khakham, C. (2023, April 6). Understanding Your Risk of Cardiovascular Disease With Functional Medicine Labs. Rupa Health.
  30. Khera, M., Bhattacharyya, S., & Miller, L. E. (2023). Effect of aerobic exercise on erectile function: systematic review and meta-analysis of randomized controlled trials. The Journal of Sexual Medicine, 20(12), 1369–1375.
  31. Kolber, M. R., & Scrimshaw, C. (2014). Family history of cardiovascular disease. Canadian Family Physician Medecin de Famille Canadien, 60(11), 1016.
  32. Kovac, J. R., Labbate, C., Ramasamy, R., et al. (2014). Effects of cigarette smoking on erectile dysfunction. Andrologia, 47(10), 1087–1092.
  33. Kresge, K. (2022, April 15). 4 Possible Causes Of Parkinson's And 5 Things That Make It Worse. Rupa Health.
  34. Maholy, N. (2023, July 17). Top Labs to Run Bi-Annually on Your Patients Experiencing Sleep Disorders. Rupa Health.
  35. Matsui, H., Sopko, N., Hannan, J., et al. (2015). Pathophysiology of Erectile Dysfunction. Current Drug Targets, 16(5), 411–419.
  36. Menees, S., & Chey, W. (2018). The gut microbiome and irritable bowel syndrome. F1000Research, 7(1), 1029.
  37. Miller, T. A. (2000). Diagnostic Evaluation of Erectile Dysfunction. American Family Physician, 61(1), 95–104.
  38. Mima, M., Huang, J. B., Andriole, G. L., et al. (2022). The impact of smoking on sexual function. BJU International, 130(2), 186–192.
  39. Montorsi, F., Briganti, A., Salonia, A., et al. (2003). Erectile Dysfunction Prevalence, Time of Onset and Association with Risk Factors in 300 Consecutive Patients with Acute Chest Pain and Angiographically Documented Coronary Artery Disease. European Urology, 44(3), 360–365.
  40. Musicki, B., Bella, A. J., Bivalacqua, T. J., et al. (2015). Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction. The Journal of Sexual Medicine, 12(12), 2233–2255.
  41. Nystoriak, M. A., & Bhatnagar, A. (2018). Cardiovascular Effects and Benefits of Exercise. Frontiers in Cardiovascular Medicine, 5(135).
  42. Pinckard, K., Baskin, K. K., & Stanford, K. I. (2019). Effects of Exercise to Improve Cardiovascular Health. Frontiers in Cardiovascular Medicine, 6(69).
  43. Rew, K. T., & Heidelbaugh, J. J. (2016). Erectile Dysfunction. American Family Physician, 94(10), 820–827.
  44. Sai Ravi Shanker, A., Phanikrishna, B., & Bhaktha Vatsala Reddy, C. (2013). Association between erectile dysfunction and coronary artery disease and its severity. Indian Heart Journal, 65(2), 180–186.
  45. Sheng, Z. (2021). Psychological consequences of erectile dysfunction. Trends in Urology & Men's Health, 12(6), 19–22.
  46. Sooriyamoorthy, T., & Leslie, S. W. (2022). Erectile Dysfunction. PubMed; StatPearls Publishing.
  47. Thompson, I. M. (2005). Erectile Dysfunction and Subsequent Cardiovascular Disease. JAMA, 294(23), 2996.
  48. Understanding Your Risk for Heart Disease. (2019, March 14). UCSF Health.
  49. Vlachopoulos, C. V., Terentes-Printzios, D. G., Ioakeimidis, N. K., et al. (2013). Prediction of Cardiovascular Events and All-Cause Mortality With Erectile Dysfunction. Circulation: Cardiovascular Quality and Outcomes, 6(1), 99–109.
  50. Weinberg, J. L. (2022, November 16). What Is the Mediterranean Diet? Rupa Health.
  51. Weinberg, J. L. (2023, December 26). The Gut-Heart Connection: Functional Medicine's Approach to Cardiovascular Health. Rupa Health.
  52. What Is Atherosclerosis? (2022). National Heart, Lung, and Blood Institute.
  53. What is Cardiovascular Disease? (2017, May 31). American Heart Association.
  54. Wu, H., & Chiou, J. (2021). Potential Benefits of Probiotics and Prebiotics for Coronary Heart Disease and Stroke. Nutrients, 13(8), 2878.
  55. Xiao, Y., Xie, T., Peng, J., et al. (2023). Factors associated with anxiety and depression in patients with erectile dysfunction: a cross-sectional study. BMC Psychology, 11(1).
Subscribe to the Magazine for free. to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.